Please ensure Javascript is enabled for purposes of website accessibility
Doctors Try CRISPR Gene Editing for Cancer, a 1st in the US
gvw_ap_news
By Associated Press
Published 5 years ago on
November 6, 2019

Share

The first attempt in the United States to use a gene editing tool called CRISPR against cancer seems safe in the three patients who have had it so far, but it’s too soon to know if it will improve survival, doctors reported Wednesday.

“It’s the most complicated genetic, cellular engineering that’s been attempted so far. This is proof that we can safely do gene editing of these cells.” Dr. Edward Stadtmauer of the University of Pennsylvania in Philadelphia
The doctors were able to take immune system cells from the patients’ blood and alter them genetically to help them recognize and fight cancer, with minimal and manageable side effects.
The treatment deletes three genes that might have been hindering these cells’ ability to attack the disease, and adds a new, fourth feature to help them do the job.
“It’s the most complicated genetic, cellular engineering that’s been attempted so far,” said the study leader, Dr. Edward Stadtmauer of the University of Pennsylvania in Philadelphia. “This is proof that we can safely do gene editing of these cells.”
After two to three months, one patient’s cancer continued to worsen and another was stable. The third patient was treated too recently to know how she’ll fare. The plan is to treat 15 more patients and assess safety and how well it works.

Chinese Scientists Reportedly Have Tried This for Cancer Patients

“It’s very early, but I’m incredibly encouraged by this,” said one independent expert, Dr. Aaron Gerds, a Cleveland Clinic cancer specialist.

This study is not aimed at changing DNA within a person’s body. Instead it seeks to remove, alter and give back to the patient cells that are super-powered to fight their cancer — a form of immunotherapy.
Other cell therapies for some blood cancers “have been a huge hit, taking diseases that are uncurable and curing them,” and the gene editing may give a way to improve on those, he said.
Gene editing is a way to permanently change DNA to attack the root causes of a disease. CRISPR is a tool to cut DNA at a specific spot. It’s long been used in the lab and is being tried for other diseases.
This study is not aimed at changing DNA within a person’s body. Instead it seeks to remove, alter and give back to the patient cells that are super-powered to fight their cancer — a form of immunotherapy.
Chinese scientists reportedly have tried this for cancer patients, but this is the first such study outside that country. It’s so novel that it took more than two years to get approval from U.S. government regulators to try it.
The early results were released by the American Society of Hematology; details will be given at its annual conference in December.

So Far, the Cells Have Survived and Have Been Multiplying as Intended

The study is sponsored by the University of Pennsylvania, the Parker Institute for Cancer Immunotherapy in San Francisco, and a biotech company, Tmunity Therapeutics. Several study leaders and the university have a financial stake in the company and may benefit from patents and licenses on the technology.
Two of the patients have multiple myeloma, a blood cancer, and the third has a sarcoma, cancer that forms in connective or soft tissue. All had failed multiple standard treatments and were out of good options.
Their blood was filtered to remove immune system soldiers called T cells, which were modified in the lab and then returned to the patients through an IV. It’s intended as a one-time treatment. The cells should multiply into an army within the body and act as a living drug.
So far, the cells have survived and have been multiplying as intended, Stadtmauer said.
“This is a brand new therapy” so not it’s not clear how soon any anti-cancer effects will be seen. Following these patients longer, and testing more of them, will tell, he said.

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

US Supreme Court Appears Likely to Uphold Obamacare’s Preventive Care Coverage Mandate

DON'T MISS

Woman in Fresno Mansion Fraud Case Sentenced to Prison for Tax Evasion

DON'T MISS

California Prisoner Indicted for Exploiting Child Victim While Incarcerated

DON'T MISS

Kennedy Plans to Phase Out 8 Commonly Used Food Dyes

DON'T MISS

The Superintendent Search Document FUSD Does Not Want You to See

DON'T MISS

Trump Approval Rating Dips. Many Wary of His Wielding of Power, Reuters/Ipsos Poll Finds

DON'T MISS

Fresno Woman, Tied to Fentanyl ‘M30 King,’ Sentenced to Federal Prison

DON'T MISS

Tesla Settles Wrongful Death Lawsuit Claiming Sudden Acceleration in Ohio Crash

DON'T MISS

Trump Is Dismantling the Education Dept. How That Might Harm Special Ed

DON'T MISS

Special Interests Pour More Than Half a Billion Into CA Lobbying

UP NEXT

Chargers in Need of Help at Wide Receiver and Tight End in the NFL Draft

UP NEXT

Magic Happens When Kids and Adults Learn to Swim. Tragedy Can Strike if They Don’t.

UP NEXT

Humanoid Robots Run a Chinese Half-Marathon Alongside Human Competitors

UP NEXT

Anti-Trump Protesters Turn Out to Rallies Across Country

UP NEXT

250 Years After America Went to War for Independence, a Divided Nation Battles Over Its Legacy

UP NEXT

Greg Cronin Fired as Coach of Anaheim Ducks After 2 Seasons

UP NEXT

Israeli Strikes on Gaza Kill More Than 90 People in 48 Hours, Palestinians Say

UP NEXT

US and Iran Advance Nuclear Talks to Expert Level After Rome Meeting

UP NEXT

Putin Announces an Easter Ceasefire as Russia and Ukraine Swap Hundreds of POWs

UP NEXT

NBA Playoff Guide: Who Plays When, How to Watch, What the Odds Are

Kennedy Plans to Phase Out 8 Commonly Used Food Dyes

20 minutes ago

The Superintendent Search Document FUSD Does Not Want You to See

23 minutes ago

Trump Approval Rating Dips. Many Wary of His Wielding of Power, Reuters/Ipsos Poll Finds

31 minutes ago

Fresno Woman, Tied to Fentanyl ‘M30 King,’ Sentenced to Federal Prison

1 hour ago

Tesla Settles Wrongful Death Lawsuit Claiming Sudden Acceleration in Ohio Crash

1 hour ago

Trump Is Dismantling the Education Dept. How That Might Harm Special Ed

2 hours ago

Special Interests Pour More Than Half a Billion Into CA Lobbying

2 hours ago

Texas Walmart Shooter Who Killed 23 Avoids Death Penalty by Pleading Guilty

3 hours ago

Chevron Announces First Oil at Ballymore Project in US Gulf

4 hours ago

Fresno Barbershop Shooting Leaves Man Dead, Two Others Injured

4 hours ago

US Supreme Court Appears Likely to Uphold Obamacare’s Preventive Care Coverage Mandate

WASHINGTON — The Supreme Court seemed likely to uphold a key preventive-care provision of the Affordable Care Act in a case heard Monday. Co...

20 seconds ago

20 seconds ago

US Supreme Court Appears Likely to Uphold Obamacare’s Preventive Care Coverage Mandate

Pilar Rose, 51, formerly of Fresno, pleaded guilty to tax evasion and obstructing an IRS audit, agreeing to forfeit her mansion and BMW after falsifying financial records to evade taxes and secure fraudulent loans. (Zillow)
8 minutes ago

Woman in Fresno Mansion Fraud Case Sentenced to Prison for Tax Evasion

Nathaniel Ray Diaz, 21, of Greenfield, is a California state prisoner who has been indicted on federal charges on Monday, April 21, 2025, for allegedly directing a minor to send sexually explicit images while serving time for previous offenses against the same child. (Shutterstock)
18 minutes ago

California Prisoner Indicted for Exploiting Child Victim While Incarcerated

Health and Human Services Secretary Robert F. Kennedy Jr. speaks at a news conference about the Centers for Disease Control and Prevention’s latest autism survey in Washington, April 16, 2025. In his first attempt to significantly change the nation’s food supply, Kennedy will direct food manufacturers to phase out eight petroleum-based food dyes that are found in hundreds of thousands of grocery-store staples, the department said on Monday, April 21. (Pete Kiehart/The New York Times)
20 minutes ago

Kennedy Plans to Phase Out 8 Commonly Used Food Dyes

23 minutes ago

The Superintendent Search Document FUSD Does Not Want You to See

President Donald Trump attends the annual White House Easter Egg Roll, on the South Lawn of the White House in Washington, D.C., U.S., April 21, 2025. (REUTERS/Leah Millis)
31 minutes ago

Trump Approval Rating Dips. Many Wary of His Wielding of Power, Reuters/Ipsos Poll Finds

1 hour ago

Fresno Woman, Tied to Fentanyl ‘M30 King,’ Sentenced to Federal Prison

A Tesla logo is shown on a Model Y vehicle in Encinitas, California, U.S.,October 20, 2023. (REUTERS/Mike Blake)
1 hour ago

Tesla Settles Wrongful Death Lawsuit Claiming Sudden Acceleration in Ohio Crash

Help continue the work that gets you the news that matters most.

Search

Send this to a friend